AI Science Tracker

Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences

2 discoveries from 2024 to 2025

Discoveries

AlphaCD maps experimentally measured catalytic properties across cytidine deaminases and supports a high-fidelity editor

The researchers measured catalytic efficiency, editing windows, motif preferences and off-target activity for 1,100 APOBEC-like cytidine deaminases fused to nCas9 in HEK293T cells, then trained AlphaCD to predict these properties. They applied it to 21,335 UniProt deaminases and experimentally checked a 28-protein subsample. As an application, the team used AlphaCD to identify a high-efficiency deaminase and alanine scanning to produce the E100A variant, which retained editing activity while reducing off-target activity; cell experiments tested editing at endogenous loci and a PCSK9 splice site.

Technology: AlphaCD, a machine-learning model trained on sequence, predicted structure and related protein features

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The researchers measured catalytic efficiency, editing windows, motif preferences and off-target activity for 1,100 APOBEC-like cytidine deaminases fused to nCas9 in HEK293T cells, then trained AlphaCD to predict these properties.
  • Still unknown: The large functional dataset was measured in HEK293T reporter assays. The 21,335-protein landscape is model-predicted, with a 28-protein validation subsample. The engineered E100A editor was tested in cells; these experiments do not establish therapeutic safety, in-vivo efficacy or clinical benefit. This is distinct from the earlier AlphaFold2 structural-clustering papers: the named discovery and assay here concern the 1,100-enzyme dataset, AlphaCD predictions and A0A2R2Z4E4 E100A variant, not CD0208^P52A or the 2023 DddA-like clade findings.
  • AI role: AlphaCD learned experimentally measured activity, editing-window, motif and off-target properties across 1,100 deaminases, predicted properties for 21,335 database sequences, and was applied to select a high-efficiency candidate for subsequent alanine-scanning engineering. The authors report the model's predictions validated on 28 sampled deaminases; the E100A mutation itself was experimentally produced by alanine scanning, not generated by the model.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/40825882/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 80 of works of the same type, year and subfield (OpenAlex work metrics, 7 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

AlphaFold2-guided mining identifies context-independent cytidine deaminases for efficient base editing

Researchers used AlphaFold2 to predict structures for 1,483 cytidine deaminases, clustered the predictions and experimentally characterized representatives. The screen identified previously uncharacterized enzymes with high editing efficiency, and CD0208^P52A showed little sequence-context preference across AC/GC/TC/CC motifs, a narrow editing window and relatively low off-target activity. In mammalian cells, its base editor introduced stop codons in single- and multicopy genes without DNA double-strand breaks.

Technology: AlphaFold2 protein-structure prediction, followed by structural clustering of candidate cytidine deaminases

Family AlphaFold: profile · models page

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Researchers used AlphaFold2 to predict structures for 1,483 cytidine deaminases, clustered the predictions and experimentally characterized representatives.
  • Still unknown: The base-editing experiments were preclinical cell experiments, not animal or clinical efficacy tests. AlphaFold2 supplied predicted rather than experimentally solved structures. The paper reports multiple promising deaminases; CD0208^P52A is the specific context-independent editor highlighted here. No therapeutic safety or in-vivo delivery claim is implied.
  • AI role: AlphaFold2-predicted structures at scale were used to mine and cluster 1,483 putative deaminases; representatives were then selected for experimental characterization in cytosine base editors. The model enabled structure-guided candidate selection; editing outcomes were measured experimentally in mammalian cells.

Evidence sources: https://www.nature.com/articles/s41551-024-01220-8.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 37 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.